An Artificial Intelligence-powered Approach to Precision Immunotherapy of Human Arthritis

NCT07013110 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

124

Enrollment

OTHER

Sponsor class

Conditions

Rheumatoid Arthritis (RA)
Rheumatology

Interventions

DRUG: dnaJP1
DRUG: Placebo

Sponsor

Prof Salvatore Albani

Collaborators

[object Object]